miR-323-3p by regulating AKT/ERK pathway via targeting transmembrane protein with EGF-like and 2 follistatin domain (TMEFF2) could inhibit apoptosis in NSCLC. The gene discussed is EGF; the disease is non-small cell lung carcinoma.